Of note, Khalili et al., proposed that PI3K inhibition enhance the effects of MEK inhibition and the combination may be an effective therapy in uveal melanoma, particularly in a GNAQ mutant background (Khalili et al., 2012). The gene discussed is MAP2K7; the disease is uveal melanoma.